ArticleHuman gene therapy2019

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.

Constanze Radek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.